Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01843452 | Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal | terminated | Phase 2 | 8 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT01233544 | Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases(RAS01) | terminated | Phase 3 | 300 | University of AarhusOTHER | 2 |
| May 12, 2016 |
| clinicaltrials |
| NCT01483638 | Axitinib as Maintenance Treatment in Patients With Metastatic CRC(TTD-11-01) | terminated | Phase 2 | 84 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT00603577 | Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens(XENON) | terminated | Phase 3 | 102 | SanofiINDUSTRY | 8 | May 5, 2016 | clinicaltrials |
| NCT00973193 | Preoperative Panitumumab and Radiotherapy in Rectal Cancer(PrePaRad) | terminated | Phase 2 | 20 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02317731 | Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation | terminated | N/A | 20 | Yale UniversityOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT01858662 | Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors | terminated | Phase 2 | 4 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT00865527 | Pilot Study of Colon Cancer Screening Tests | terminated | N/A | 198 | Hamilton Health Sciences CorporationOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02720926 | Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer | terminated | Phase 1 | 3 | National Cancer Centre, SingaporeOTHER | 1 | Mar 28, 2016 | clinicaltrials |
| NCT00131586 | Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins | terminated | — | 100 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT01384240 | Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia | terminated | Early Phase 1 | 183 | Anandasabapathy, Sharmila, M.D.INDIV | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00305643 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | terminated | Phase 3 | 11 | M.D. Anderson Cancer CenterOTHER | 2 | Dec 24, 2015 | clinicaltrials |
| NCT00271011 | A Study of Mitomycin C, Irinotecan, and Cetuximab | terminated | Phase 2 | 13 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT01186705 | Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer | terminated | Phase 2 | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01816659 | An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | terminated | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00019747 | Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer | terminated | Phase 2 | 39 | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 28, 2015 | clinicaltrials |
| NCT01856322 | Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | terminated | Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01004159 | Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan | terminated | Phase 2 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00717990 | Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment | terminated | Phase 2 | 15 | University Hospital of CreteOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | terminated | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00899132 | Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | terminated | — | 180 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00250835 | Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer | terminated | Phase 2 | 38 | New Mexico Cancer Research AllianceOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT02109224 | Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection | terminated | Phase 1 | 72 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2015 | clinicaltrials |
| NCT01062919 | Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery | terminated | N/A | 10 | Franco CarliOTHER | 1 | Aug 4, 2015 | clinicaltrials |
| NCT01300858 | A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients | terminated | Phase 1 / Phase 2 | 4 | EGEN, Inc.INDUSTRY | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00099346 | MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) | terminated | Phase 1 | — | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 17, 2015 | clinicaltrials |
| NCT00396487 | Tailored Treatment in Metastatic Colorectal Cancer | terminated | Phase 3 | 1 | Vejle HospitalOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer(PEPCOL) | terminated | Phase 2 | 55 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | terminated | Phase 1 | 7 | University of Southern CaliforniaOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01198535 | Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | May 18, 2015 | clinicaltrials |
| NCT00459901 | Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 13 | Peter KozuchOTHER | 1 | Apr 29, 2015 | clinicaltrials |
| NCT01507740 | Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients | terminated | — | 60 | Medical University InnsbruckOTHER | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00826800 | Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer | terminated | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01440127 | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers | terminated | Phase 1 | 9 | Tufts Medical CenterOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT01706822 | Radial Reload Laparoscopic LAR Case Series | terminated | Phase 4 | 8 | Medtronic - MITGINDUSTRY | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab(BEBYP) | terminated | Phase 3 | 184 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01717014 | Radial Reload Open LAR Case Series | terminated | N/A | 8 | Medtronic - MITGINDUSTRY | 1 | Mar 2, 2015 | clinicaltrials |
| NCT00003843 | Irinotecan in Treating Patients With Colorectal Cancer | terminated | — | 28 | California Cancer ConsortiumNETWORK | 1 | Feb 16, 2015 | clinicaltrials |
| NCT01544452 | Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer | terminated | N/A | 75 | Herlev HospitalOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00959738 | Diverting Loop Ileostomy: With or Without Rod(ROLLI) | terminated | N/A | 121 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT00823810 | Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT(RESCORE) | terminated | N/A | 20 | Turku University HospitalOTHER_GOV | 1 | Oct 9, 2014 | clinicaltrials |
| NCT00390364 | Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy | terminated | Phase 2 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT01149434 | Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers | terminated | Phase 1 / Phase 2 | 19 | University of UtahOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00642746 | Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) | terminated | Phase 2 | 16 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02228785 | A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer(CC1C) | terminated | Phase 2 | 5 | Cancer Advances Inc.INDUSTRY | 0 | Aug 29, 2014 | clinicaltrials |
| NCT00538291 | Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | terminated | Phase 2 | 13 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01365910 | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer | terminated | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | terminated | Phase 3 | 72 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02204332 | Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment(COMETA) | terminated | Phase 2 | 38 | Hospital Clinico Universitario de SantiagoOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 21, 2014 | clinicaltrials |
Data updated 24 days agoSource updated May 19, 2016source: clinicaltrials